Base Therapeutics
Zhuhai · Founded 2021
About Base Therapeutics
Base Therapeutics offers cell and gene editing technology designed to treat cancerous diseases. The company's technology includes a natural killer cell genetic engineering platform and other cell therapy products for treatments of lung cancer, liver cancer, glioma, and other hematological tumors
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.4M
- Last round: Series Unknown (Aug 2025)
- Website: https://basetherapeutics.com/
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/base-therapeutics-145513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.